Fundz

Swarm Oncology forms research collaboration with a leading US clinic to enhance T cell therapies for advanced solid cancers.

Oct 28, 2025

Contract Type

partnership

LondonBiotechnologyHealth CareMedicalTherapeuticsresearch

Description

Swarm Oncology Ltd. has announced a partnership with a US clinic to advance research in T cell therapies. This collaboration will use patient blood samples to evaluate immune responses and manufacture personalized T cell products. The partnership aims to improve survival outcomes for patients with solid cancers.

Company Information

Company

Swarm Oncology Ltd

Location

London, England, United Kingdom

About

Swarm Oncology is a biotechnology company focused on developing innovative T cell therapies for patients with advanced solid cancers. Their research aims to achieve long-term remission through enhanced immune responses. The company's platform aims to improve the effectiveness of cancer vaccines. Swarm is dedicated to addressing significant unmet needs in cancer treatment.

Predictive Intelligence
Strategic

ML-powered predictions for Swarm Oncology Ltd's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Swarm Oncology Ltd signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.